We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

NYSE:TAK

Takeda Pharmaceutical Company Limited (TAK)

NYSE • TAK • US8740602052

21.06Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 0.1% of free float is sold short, 1.1 days to cover, cost to borrow 0.46%.

Market Cap

66.3b USD | # 354 in US

Volume

2.68m shares | 50.09m USD

Shares Outstanding

3.19b

Free Float Shares

96.86% | 3.09b

OTCPK:TKPH.F|

DB:TKD|

DB:TKDA|

LSE:0A87|

TSE:4502|

BOVESPA:TAKP34|

WBAG:TKD

News

TAK key data

Takeda Pharmaceutical Company Limited (NYSE: TAK) has a market capitalization of $66.3B. Last close $21.06 (as of 2026-11-05); 52-week range $13.50 to $21.22. ORTEX data as of 2026-11-03: short interest is 0.11% of free float, 1.1 days to cover and the average cost to borrow is 0.46%.

TAK news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.